Revenue Growth Amid Pandemic Helps Trxade Group, Inc. (NASDAQ: MEDS) Build its Transparency in Pharmaceuticals Strategy
Pharmaceutical services innovator Trxade Group Inc. has gained investor attention as it has emerged as a responsive healthcare market force during the ongoing COVID-19 pandemic As the pandemic began to unfold earlier this year, Trxade Group saw revenues jump effectively to three times their previous Q1 level, largely as a result of personal protective equipment products The company’s core mission has been to help small, community-centered retail pharmacies compete with large national chains through prescription drug price transparency and AI-driven protocols that help pharmacies stay abreast of what’s available Trxade Group’s advances in delivering services ranging from consultation to drug…